Advertisement

Index by author

June 01, 1997; Volume 25,Issue 6

A

  1. Acosta, Daniel

    1. Metabolism of Ketoconazole and Deacetylated Ketoconazole by Rat Hepatic Microsomes and Flavin-Containing Monooxygenases
      Rosita J. Rodriguez and Daniel Acosta
      Drug Metabolism and Disposition June 1997, 25 (6) 772-777;

B

  1. Bao, Jingqi

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  2. Barnett, C. J.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  3. Berkhout, Theo A.

    1. Induction of Cytochrome P4503A by the Antiglucocorticoid Mifepristone and a Novel Hypocholesterolaemic Drug
      J. Andrew Williams, Richard J. Chenery, Theo A. Berkhout and Gabrielle M. Hawksworth
      Drug Metabolism and Disposition June 1997, 25 (6) 757-761;

  4. Bickel, Ulrich

    1. Blood-Brain Barrier Permeability to Morphine-6-Glucuronide is Markedly Reduced Compared with Morphine
      Dafang Wu, Young-Sook Kang, Ulrich Bickel and William M. Pardridge
      Drug Metabolism and Disposition June 1997, 25 (6) 768-771;

C

  1. Chenery, Richard J.

    1. Induction of Cytochrome P4503A by the Antiglucocorticoid Mifepristone and a Novel Hypocholesterolaemic Drug
      J. Andrew Williams, Richard J. Chenery, Theo A. Berkhout and Gabrielle M. Hawksworth
      Drug Metabolism and Disposition June 1997, 25 (6) 757-761;

  2. Christiansen, Eyøhild

    1. Purification and 1H NMR Spectroscopic Characterization of Phase II Metabolites of Tolfenamic Acid
      Ulla Grove Sidelmann, Eyøhild Christiansen, Line Krogh, Claus Cornett and Jette Tjørnelund, and Steen Honoré Hansen
      Drug Metabolism and Disposition June 1997, 25 (6) 725-731;

  3. Cornett, Claus

    1. Purification and 1H NMR Spectroscopic Characterization of Phase II Metabolites of Tolfenamic Acid
      Ulla Grove Sidelmann, Eyøhild Christiansen, Line Krogh, Claus Cornett and Jette Tjørnelund, and Steen Honoré Hansen
      Drug Metabolism and Disposition June 1997, 25 (6) 725-731;

  4. Coutts, R. T.

    1. Stereoselective Metabolism of rac-Mexiletine by the Fungus Cunninghamella echinulata Yields the Major Human Metabolites Hydroxymethylmexiletine andp-Hydroxymexiletine
      D. G. Freitag, R. T. Foster, R. T. Coutts, M. A. Pickard and F. M. Pasutto
      Drug Metabolism and Disposition June 1997, 25 (6) 685-692;

D

  1. Davis, Patrick J.

    1. Microbial Models of Mammalian Metabolism
      Geeta P. Rao and Patrick J. Davis
      Drug Metabolism and Disposition June 1997, 25 (6) 709-715;

  2. Dorman, D. E.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  3. Dragnev, Konstantin H.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

E

  1. Ehlhardt, W. J.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  2. Ehlhardt, William J.

    1. Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey
      William J. Ehlhardt, Joseph M. Woodland, John E. Toth, James E. Ray and Diana L. Martin
      Drug Metabolism and Disposition June 1997, 25 (6) 701-708;

F

  1. Foster, R. T.

    1. Stereoselective Metabolism of rac-Mexiletine by the Fungus Cunninghamella echinulata Yields the Major Human Metabolites Hydroxymethylmexiletine andp-Hydroxymexiletine
      D. G. Freitag, R. T. Foster, R. T. Coutts, M. A. Pickard and F. M. Pasutto
      Drug Metabolism and Disposition June 1997, 25 (6) 685-692;

  2. Freitag, D. G.

    1. Stereoselective Metabolism of rac-Mexiletine by the Fungus Cunninghamella echinulata Yields the Major Human Metabolites Hydroxymethylmexiletine andp-Hydroxymexiletine
      D. G. Freitag, R. T. Foster, R. T. Coutts, M. A. Pickard and F. M. Pasutto
      Drug Metabolism and Disposition June 1997, 25 (6) 685-692;

  3. Funae, Yoshihiko

    1. CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS
      Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki
      Drug Metabolism and Disposition June 1997, 25 (6) 716-724;

G

  1. Gruber, J. M.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

H

  1. Hansen, Jette Tjørnelund, and Steen Honoré

    1. Purification and 1H NMR Spectroscopic Characterization of Phase II Metabolites of Tolfenamic Acid
      Ulla Grove Sidelmann, Eyøhild Christiansen, Line Krogh, Claus Cornett and Jette Tjørnelund, and Steen Honoré Hansen
      Drug Metabolism and Disposition June 1997, 25 (6) 725-731;

  2. Haraguchi, Kaori

    1. Prediction of Drug-Induced Catalepsy Based on Dopamine D1, D2, and Muscarinic Acetylcholine Receptor Occupancies
      Kaori Haraguchi, Kiyomi Ito, Hajime Kotaki, Yasufumi Sawada and Tatsuji Iga
      Drug Metabolism and Disposition June 1997, 25 (6) 675-684;

  3. Hawksworth, Gabrielle M.

    1. Induction of Cytochrome P4503A by the Antiglucocorticoid Mifepristone and a Novel Hypocholesterolaemic Drug
      J. Andrew Williams, Richard J. Chenery, Theo A. Berkhout and Gabrielle M. Hawksworth
      Drug Metabolism and Disposition June 1997, 25 (6) 757-761;

I

  1. Iga, Tatsuji

    1. Prediction of Drug-Induced Catalepsy Based on Dopamine D1, D2, and Muscarinic Acetylcholine Receptor Occupancies
      Kaori Haraguchi, Kiyomi Ito, Hajime Kotaki, Yasufumi Sawada and Tatsuji Iga
      Drug Metabolism and Disposition June 1997, 25 (6) 675-684;

  2. Inoue, Kazuaki

    1. CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS
      Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki
      Drug Metabolism and Disposition June 1997, 25 (6) 716-724;

  3. Ito, Kiyomi

    1. Prediction of Drug-Induced Catalepsy Based on Dopamine D1, D2, and Muscarinic Acetylcholine Receptor Occupancies
      Kaori Haraguchi, Kiyomi Ito, Hajime Kotaki, Yasufumi Sawada and Tatsuji Iga
      Drug Metabolism and Disposition June 1997, 25 (6) 675-684;

J

  1. Jones, Collins R.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

K

  1. Kamataki, Tetsuya

    1. CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS
      Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki
      Drug Metabolism and Disposition June 1997, 25 (6) 716-724;

  2. Kang, Young-Sook

    1. Blood-Brain Barrier Permeability to Morphine-6-Glucuronide is Markedly Reduced Compared with Morphine
      Dafang Wu, Young-Sook Kang, Ulrich Bickel and William M. Pardridge
      Drug Metabolism and Disposition June 1997, 25 (6) 768-771;

  3. Kashiyama, Eiji

    1. CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS
      Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki
      Drug Metabolism and Disposition June 1997, 25 (6) 716-724;

  4. Kattnig, Margaret J.

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  5. Kitani, Mami

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;

  6. Kotaki, Hajime

    1. Prediction of Drug-Induced Catalepsy Based on Dopamine D1, D2, and Muscarinic Acetylcholine Receptor Occupancies
      Kaori Haraguchi, Kiyomi Ito, Hajime Kotaki, Yasufumi Sawada and Tatsuji Iga
      Drug Metabolism and Disposition June 1997, 25 (6) 675-684;

  7. Krogh, Line

    1. Purification and 1H NMR Spectroscopic Characterization of Phase II Metabolites of Tolfenamic Acid
      Ulla Grove Sidelmann, Eyøhild Christiansen, Line Krogh, Claus Cornett and Jette Tjørnelund, and Steen Honoré Hansen
      Drug Metabolism and Disposition June 1997, 25 (6) 725-731;

  8. Kuester, Robert K.

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

L

  1. Linnet, Kristian

    1. Hydroxylation and Demethylation of the Tricyclic Antidepressant Nortriptyline by cDNA-Expressed Human Cytochrome P-450 Isozymes
      Ole V. Olesen and Kristian Linnet
      Drug Metabolism and Disposition June 1997, 25 (6) 740-744;

  2. Lu, Anthony Y. H.

    1. Inhibitory Anti-Peptide Antibody Against Human CYP3A4
      Regina W. Wang and Anthony Y. H. Lu
      Drug Metabolism and Disposition June 1997, 25 (6) 762-767;

  3. Lubet, Ronald A.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

M

  1. Martin, Diana L.

    1. Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey
      William J. Ehlhardt, Joseph M. Woodland, John E. Toth, James E. Ray and Diana L. Martin
      Drug Metabolism and Disposition June 1997, 25 (6) 701-708;

  2. Matsubara, Jun

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;

  3. Mayersohn, Michael

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  4. McClure, Thomas D.

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  5. Miyamoto, Gohachiro

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;

N

  1. Nagasawa, Masakazu

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;

  2. Nguyen, Nghia

    1. Baculovirus-Directed Expression of Rabbit UDP-Glucuronosyltransferases in Spodoptera frugiperda Cells
      Nghia Nguyen and Robert H. Tukey
      Drug Metabolism and Disposition June 1997, 25 (6) 745-749;

  3. Nims, Raymond W.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

O

  1. Odomi, Masaaki

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;
    2. CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS
      Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki
      Drug Metabolism and Disposition June 1997, 25 (6) 716-724;

  2. Olesen, Ole V.

    1. Hydroxylation and Demethylation of the Tricyclic Antidepressant Nortriptyline by cDNA-Expressed Human Cytochrome P-450 Isozymes
      Ole V. Olesen and Kristian Linnet
      Drug Metabolism and Disposition June 1997, 25 (6) 740-744;

P

  1. Pardridge, William M.

    1. Blood-Brain Barrier Permeability to Morphine-6-Glucuronide is Markedly Reduced Compared with Morphine
      Dafang Wu, Young-Sook Kang, Ulrich Bickel and William M. Pardridge
      Drug Metabolism and Disposition June 1997, 25 (6) 768-771;

  2. Pasutto, F. M.

    1. Stereoselective Metabolism of rac-Mexiletine by the Fungus Cunninghamella echinulata Yields the Major Human Metabolites Hydroxymethylmexiletine andp-Hydroxymexiletine
      D. G. Freitag, R. T. Foster, R. T. Coutts, M. A. Pickard and F. M. Pasutto
      Drug Metabolism and Disposition June 1997, 25 (6) 685-692;

  3. Pickard, M. A.

    1. Stereoselective Metabolism of rac-Mexiletine by the Fungus Cunninghamella echinulata Yields the Major Human Metabolites Hydroxymethylmexiletine andp-Hydroxymexiletine
      D. G. Freitag, R. T. Foster, R. T. Coutts, M. A. Pickard and F. M. Pasutto
      Drug Metabolism and Disposition June 1997, 25 (6) 685-692;

  4. Prough, Russell A.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

R

  1. Rao, Geeta P.

    1. Microbial Models of Mammalian Metabolism
      Geeta P. Rao and Patrick J. Davis
      Drug Metabolism and Disposition June 1997, 25 (6) 709-715;

  2. Ray, James E.

    1. Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey
      William J. Ehlhardt, Joseph M. Woodland, John E. Toth, James E. Ray and Diana L. Martin
      Drug Metabolism and Disposition June 1997, 25 (6) 701-708;

  3. Rodriguez, Rosita J.

    1. Metabolism of Ketoconazole and Deacetylated Ketoconazole by Rat Hepatic Microsomes and Flavin-Containing Monooxygenases
      Rosita J. Rodriguez and Daniel Acosta
      Drug Metabolism and Disposition June 1997, 25 (6) 772-777;

S

  1. Sauer, John-Michael

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  2. Sawada, Yasufumi

    1. Prediction of Drug-Induced Catalepsy Based on Dopamine D1, D2, and Muscarinic Acetylcholine Receptor Occupancies
      Kaori Haraguchi, Kiyomi Ito, Hajime Kotaki, Yasufumi Sawada and Tatsuji Iga
      Drug Metabolism and Disposition June 1997, 25 (6) 675-684;

  3. Shih, C.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  4. Shin, Ho-Sang

    1. Metabolism of Selegiline in Humans
      Ho-Sang Shin
      Drug Metabolism and Disposition June 1997, 25 (6) 657-662;

  5. Sidelmann, Ulla Grove

    1. Purification and 1H NMR Spectroscopic Characterization of Phase II Metabolites of Tolfenamic Acid
      Ulla Grove Sidelmann, Eyøhild Christiansen, Line Krogh, Claus Cornett and Jette Tjørnelund, and Steen Honoré Hansen
      Drug Metabolism and Disposition June 1997, 25 (6) 725-731;

  6. Sipes, I. Glenn

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  7. Smith, Richard L.

    1. Oral and Topical Absorption, Disposition Kinetics, and the Metabolic Fate of trans-Methyl Styryl Ketone in the Male Fischer 344 Rat
      John-Michael Sauer, Richard L. Smith, Jingqi Bao, Margaret J. Kattnig, Robert K. Kuester, Thomas D. McClure, Michael Mayersohn and I. Glenn Sipes
      Drug Metabolism and Disposition June 1997, 25 (6) 732-739;

  8. Spangle, L. A.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  9. Stockus, Diana L.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

T

  1. Thomas, Paul E.

    1. In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
      Raymond W. Nims, Russell A. Prough, Collins R. Jones, Diana L. Stockus, Konstantin H. Dragnev, Paul E. Thomas and Ronald A. Lubet
      Drug Metabolism and Disposition June 1997, 25 (6) 750-756;

  2. Toth, John E.

    1. Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey
      William J. Ehlhardt, Joseph M. Woodland, John E. Toth, James E. Ray and Diana L. Martin
      Drug Metabolism and Disposition June 1997, 25 (6) 701-708;

  3. Tukey, Robert H.

    1. Baculovirus-Directed Expression of Rabbit UDP-Glucuronosyltransferases in Spodoptera frugiperda Cells
      Nghia Nguyen and Robert H. Tukey
      Drug Metabolism and Disposition June 1997, 25 (6) 745-749;

U

  1. Uchida, Minoru

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;

W

  1. Wang, Regina W.

    1. Inhibitory Anti-Peptide Antibody Against Human CYP3A4
      Regina W. Wang and Anthony Y. H. Lu
      Drug Metabolism and Disposition June 1997, 25 (6) 762-767;

  2. Williams, J. Andrew

    1. Induction of Cytochrome P4503A by the Antiglucocorticoid Mifepristone and a Novel Hypocholesterolaemic Drug
      J. Andrew Williams, Richard J. Chenery, Theo A. Berkhout and Gabrielle M. Hawksworth
      Drug Metabolism and Disposition June 1997, 25 (6) 757-761;

  3. Wilson, T. M.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  4. Woodland, J. M.

    1. Metabolism and Disposition of the Antifolate LY231514 in Mice and Dogs
      J. M. Woodland, C. J. Barnett, D. E. Dorman, J. M. Gruber, C. Shih, L. A. Spangle, T. M. Wilson and W. J. Ehlhardt
      Drug Metabolism and Disposition June 1997, 25 (6) 693-700;

  5. Woodland, Joseph M.

    1. Disposition and metabolism of the Sulfonylurea Oncolytic Agent LY295501 in Mouse, Rat, and Monkey
      William J. Ehlhardt, Joseph M. Woodland, John E. Toth, James E. Ray and Diana L. Martin
      Drug Metabolism and Disposition June 1997, 25 (6) 701-708;

  6. Wu, Dafang

    1. Blood-Brain Barrier Permeability to Morphine-6-Glucuronide is Markedly Reduced Compared with Morphine
      Dafang Wu, Young-Sook Kang, Ulrich Bickel and William M. Pardridge
      Drug Metabolism and Disposition June 1997, 25 (6) 768-771;

Y

  1. Yamada, Toshihide

    1. Biotransformation of the Novel Inotropic Agent Toborinone (OPC-18790) in Rats and Dogs
      Mami Kitani, Gohachiro Miyamoto, Masakazu Nagasawa, Toshihide Yamada, Jun Matsubara, Minoru Uchida and Masaaki Odomi
      Drug Metabolism and Disposition June 1997, 25 (6) 663-674;

  2. Yokoi, Tsuyoshi

    1. CYTOCHROME P450 RESPONSIBLE FOR THE STEREOSELECTIVES-OXIDATION OF FLOSEQUINAN IN HEPATIC MICROSOMES FROM RATS AND HUMANS
      Eiji Kashiyama, Tsuyoshi Yokoi, Masaaki Odomi, Yoshihiko Funae, Kazuaki Inoue and Tetsuya Kamataki
      Drug Metabolism and Disposition June 1997, 25 (6) 716-724;
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 6
1 Jun 1997
Sign up for alerts
Advertisement